These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 22533388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
    Salla K, Restitutti F, Vainionpää M, Junnila J, Honkavaara J, Kuusela E, Raekallio M, Vainio O.
    Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
    [Abstract] [Full Text] [Related]

  • 3. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2-antagonist MK-467 in dogs.
    Restitutti F, Kaartinen MJ, Raekallio MR, Wejberg O, Mikkola E, Del Castillo JRE, Scheinin M, Vainio OM.
    Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the peripherally acting α2-adrenoceptor antagonist MK-467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole.
    Adam M, Raekallio MR, Salla KM, Honkavaara JM, Männikkö S, Scheinin M, Kajula M, Mölsä SH, Vainio OM.
    Am J Vet Res; 2018 Sep; 79(9):921-932. PubMed ID: 30153057
    [Abstract] [Full Text] [Related]

  • 6. Effects of intramuscular vatinoxan (MK-467), co-administered with medetomidine and butorphanol, on cardiopulmonary and anaesthetic effects of intravenous ketamine in dogs.
    Turunen H, Raekallio M, Honkavaara J, Jaakkola J, Scheinin M, Männikkö S, Hautajärvi H, Bennett R, Vainio O.
    Vet Anaesth Analg; 2020 Sep; 47(5):604-613. PubMed ID: 32682664
    [Abstract] [Full Text] [Related]

  • 7. Peripheral α2-adrenoceptor antagonism affects the absorption of intramuscularly coadministered drugs.
    Kallio-Kujala IJ, Raekallio MR, Honkavaara J, Bennett RC, Turunen H, Scheinin M, Hautajärvi H, Vainio O.
    Vet Anaesth Analg; 2018 Jul; 45(4):405-413. PubMed ID: 29891212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane.
    Salla KM, Tuns CI, Bennett RC, Raekallio MR, Scheinin M, Kuusela E, Vainio OM.
    Am J Vet Res; 2017 Nov; 78(11):1245-1254. PubMed ID: 29076369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the α2-adrenoceptor agonist medetomidine on the distribution and clearance of alfaxalone during coadministration by constant rate infusion in dogs.
    Bennett RC, Salla KM, Raekallio MR, Scheinin M, Vainio OM.
    Am J Vet Res; 2017 Aug; 78(8):956-964. PubMed ID: 28738010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
    Adam M, Raekallio MR, Vainio OM.
    Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thermographic imaging of superficial temperature in dogs sedated with medetomidine and butorphanol with and without MK-467 (L-659'066).
    Vainionpää M, Salla K, Restitutti F, Raekallio M, Junnila J, Snellman M, Vainio O.
    Vet Anaesth Analg; 2013 Mar; 40(2):142-8. PubMed ID: 22891670
    [Abstract] [Full Text] [Related]

  • 17. Concentrations of medetomidine enantiomers and vatinoxan, an α2-adrenoceptor antagonist, in plasma and central nervous tissue after intravenous coadministration in dogs.
    Honkavaara JM, Raekallio MR, Syrja PM, Pypendop BH, Knych HK, Kallio-Kujala IJ, Vainio OM.
    Vet Anaesth Analg; 2020 Jan; 47(1):47-52. PubMed ID: 31761600
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the sedative effects of medetomidine administered intranasally, by atomization or drops, and intramuscular injection in dogs.
    Jafarbeglou M, Marjani M.
    Vet Anaesth Analg; 2019 Nov; 46(6):815-819. PubMed ID: 31416698
    [Abstract] [Full Text] [Related]

  • 19. The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal.
    Adam M, Raekallio MR, Keskitalo T, Honkavaara JM, Scheinin M, Kajula M, Mölsä S, Vainio OM.
    J Vet Pharmacol Ther; 2018 Jun; 41(3):447-456. PubMed ID: 29352473
    [Abstract] [Full Text] [Related]

  • 20. Detomidine and the combination of detomidine and MK-467, a peripheral alpha-2 adrenoceptor antagonist, as premedication in horses anaesthetized with isoflurane.
    Pakkanen SA, Raekallio MR, Mykkänen AK, Salla KM, de Vries A, Vuorilehto L, Scheinin M, Vainio OM.
    Vet Anaesth Analg; 2015 Sep; 42(5):527-36. PubMed ID: 25529045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.